Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia

Julie Vallortigara, Sindhoo Rangarajan, David Whitfield, Amani Alghamdi, David Howlett, T. Hortobágyi, Mary Johnson, Johannes Attems, Clive Ballard, Alan Thomas, John O'Brien, Dag Aarsland, Paul Francis

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD) together, represent the second most common cause of dementia, after Alzheimer's disease (AD). The synaptic dysfunctions underlying the cognitive decline and psychiatric symptoms observed throughout the development of PDD and DLB are still under investigation. In this study we examined the expression level of Dynamin1 and phospho-CaMKII, key proteins of endocytosis and synaptic plasticity respectively, as potential markers of molecular processes specifically deregulated with DLB and/or PDD. In order to measure the levels of these proteins, we isolated grey matter from post-mortem prefrontal cortex area (BA9), anterior cingulated gyrus (BA24) and parietal cortex (BA40) from DLB and PDD patients in comparison to age-matched controls and a group of AD cases. Clinical and pathological data available included the MMSE score, neuropsychiatric history, and semi-quantitative scores for AD pathology (plaques - tangles) and for α-synuclein (Lewy bodies). Changes in the expression of the synaptic markers, and correlates with neuropathological features and cognitive decline were predominantly found in the prefrontal cortex. On one hand, levels of Dynamin1 were significantly reduced, and correlated with a higher rate of cognitive decline observed in cases from three dementia groups. On the other hand, the fraction of phospho-CaMKII was decreased, and correlated with a high score of plaques and tangles in BA9. Interestingly, the correlation between the rate of cognitive decline and the level of Dynamin1 remained when the analysis was restricted to the PDD and DLB cases, highlighting an association of Dynamin1 with cognitive decline in people with Lewy Body dementia.

Original languageEnglish
JournalF1000Research
Volume3
DOIs
Publication statusPublished - May 13 2014

Fingerprint

Lewy Body Disease
Prefrontal Cortex
Dementia
Parkinson Disease
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Alzheimer Disease
Synucleins
Cognitive Dysfunction
Pathology
Lewy Bodies
Parietal Lobe
Neuronal Plasticity
Plasticity
Endocytosis
Proteins
Psychiatry
History

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. / Vallortigara, Julie; Rangarajan, Sindhoo; Whitfield, David; Alghamdi, Amani; Howlett, David; Hortobágyi, T.; Johnson, Mary; Attems, Johannes; Ballard, Clive; Thomas, Alan; O'Brien, John; Aarsland, Dag; Francis, Paul.

In: F1000Research, Vol. 3, 13.05.2014.

Research output: Contribution to journalArticle

Vallortigara, J, Rangarajan, S, Whitfield, D, Alghamdi, A, Howlett, D, Hortobágyi, T, Johnson, M, Attems, J, Ballard, C, Thomas, A, O'Brien, J, Aarsland, D & Francis, P 2014, 'Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia', F1000Research, vol. 3. https://doi.org/10.12688/f1000research.3786.1
Vallortigara, Julie ; Rangarajan, Sindhoo ; Whitfield, David ; Alghamdi, Amani ; Howlett, David ; Hortobágyi, T. ; Johnson, Mary ; Attems, Johannes ; Ballard, Clive ; Thomas, Alan ; O'Brien, John ; Aarsland, Dag ; Francis, Paul. / Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. In: F1000Research. 2014 ; Vol. 3.
@article{bf56592d8f834f0a8f299e618e86b77e,
title = "Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia",
abstract = "Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD) together, represent the second most common cause of dementia, after Alzheimer's disease (AD). The synaptic dysfunctions underlying the cognitive decline and psychiatric symptoms observed throughout the development of PDD and DLB are still under investigation. In this study we examined the expression level of Dynamin1 and phospho-CaMKII, key proteins of endocytosis and synaptic plasticity respectively, as potential markers of molecular processes specifically deregulated with DLB and/or PDD. In order to measure the levels of these proteins, we isolated grey matter from post-mortem prefrontal cortex area (BA9), anterior cingulated gyrus (BA24) and parietal cortex (BA40) from DLB and PDD patients in comparison to age-matched controls and a group of AD cases. Clinical and pathological data available included the MMSE score, neuropsychiatric history, and semi-quantitative scores for AD pathology (plaques - tangles) and for α-synuclein (Lewy bodies). Changes in the expression of the synaptic markers, and correlates with neuropathological features and cognitive decline were predominantly found in the prefrontal cortex. On one hand, levels of Dynamin1 were significantly reduced, and correlated with a higher rate of cognitive decline observed in cases from three dementia groups. On the other hand, the fraction of phospho-CaMKII was decreased, and correlated with a high score of plaques and tangles in BA9. Interestingly, the correlation between the rate of cognitive decline and the level of Dynamin1 remained when the analysis was restricted to the PDD and DLB cases, highlighting an association of Dynamin1 with cognitive decline in people with Lewy Body dementia.",
author = "Julie Vallortigara and Sindhoo Rangarajan and David Whitfield and Amani Alghamdi and David Howlett and T. Hortob{\'a}gyi and Mary Johnson and Johannes Attems and Clive Ballard and Alan Thomas and John O'Brien and Dag Aarsland and Paul Francis",
year = "2014",
month = "5",
day = "13",
doi = "10.12688/f1000research.3786.1",
language = "English",
volume = "3",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia

AU - Vallortigara, Julie

AU - Rangarajan, Sindhoo

AU - Whitfield, David

AU - Alghamdi, Amani

AU - Howlett, David

AU - Hortobágyi, T.

AU - Johnson, Mary

AU - Attems, Johannes

AU - Ballard, Clive

AU - Thomas, Alan

AU - O'Brien, John

AU - Aarsland, Dag

AU - Francis, Paul

PY - 2014/5/13

Y1 - 2014/5/13

N2 - Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD) together, represent the second most common cause of dementia, after Alzheimer's disease (AD). The synaptic dysfunctions underlying the cognitive decline and psychiatric symptoms observed throughout the development of PDD and DLB are still under investigation. In this study we examined the expression level of Dynamin1 and phospho-CaMKII, key proteins of endocytosis and synaptic plasticity respectively, as potential markers of molecular processes specifically deregulated with DLB and/or PDD. In order to measure the levels of these proteins, we isolated grey matter from post-mortem prefrontal cortex area (BA9), anterior cingulated gyrus (BA24) and parietal cortex (BA40) from DLB and PDD patients in comparison to age-matched controls and a group of AD cases. Clinical and pathological data available included the MMSE score, neuropsychiatric history, and semi-quantitative scores for AD pathology (plaques - tangles) and for α-synuclein (Lewy bodies). Changes in the expression of the synaptic markers, and correlates with neuropathological features and cognitive decline were predominantly found in the prefrontal cortex. On one hand, levels of Dynamin1 were significantly reduced, and correlated with a higher rate of cognitive decline observed in cases from three dementia groups. On the other hand, the fraction of phospho-CaMKII was decreased, and correlated with a high score of plaques and tangles in BA9. Interestingly, the correlation between the rate of cognitive decline and the level of Dynamin1 remained when the analysis was restricted to the PDD and DLB cases, highlighting an association of Dynamin1 with cognitive decline in people with Lewy Body dementia.

AB - Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD) together, represent the second most common cause of dementia, after Alzheimer's disease (AD). The synaptic dysfunctions underlying the cognitive decline and psychiatric symptoms observed throughout the development of PDD and DLB are still under investigation. In this study we examined the expression level of Dynamin1 and phospho-CaMKII, key proteins of endocytosis and synaptic plasticity respectively, as potential markers of molecular processes specifically deregulated with DLB and/or PDD. In order to measure the levels of these proteins, we isolated grey matter from post-mortem prefrontal cortex area (BA9), anterior cingulated gyrus (BA24) and parietal cortex (BA40) from DLB and PDD patients in comparison to age-matched controls and a group of AD cases. Clinical and pathological data available included the MMSE score, neuropsychiatric history, and semi-quantitative scores for AD pathology (plaques - tangles) and for α-synuclein (Lewy bodies). Changes in the expression of the synaptic markers, and correlates with neuropathological features and cognitive decline were predominantly found in the prefrontal cortex. On one hand, levels of Dynamin1 were significantly reduced, and correlated with a higher rate of cognitive decline observed in cases from three dementia groups. On the other hand, the fraction of phospho-CaMKII was decreased, and correlated with a high score of plaques and tangles in BA9. Interestingly, the correlation between the rate of cognitive decline and the level of Dynamin1 remained when the analysis was restricted to the PDD and DLB cases, highlighting an association of Dynamin1 with cognitive decline in people with Lewy Body dementia.

UR - http://www.scopus.com/inward/record.url?scp=84923329654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923329654&partnerID=8YFLogxK

U2 - 10.12688/f1000research.3786.1

DO - 10.12688/f1000research.3786.1

M3 - Article

AN - SCOPUS:84923329654

VL - 3

JO - F1000Research

JF - F1000Research

SN - 2046-1402

ER -